Cargando…
Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3
Staphylococcal protein A (SpA) is a multifunctional, highly conserved virulence factor of Staphylococcus aureus. By binding the Fc portion of all human IgG subclasses apart from IgG3, SpA interferes with antibody and complement deposition on the bacterial surface, impairing staphylococcal clearance...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963248/ https://www.ncbi.nlm.nih.gov/pubmed/35359919 http://dx.doi.org/10.3389/fimmu.2022.834711 |
_version_ | 1784677951835471872 |
---|---|
author | Boero, Elena Cruz, Ana Rita Pansegrau, Werner Giovani, Cinzia Rooijakkers, Suzan H. M. van Kessel, Kok P. M. van Strijp, Jos A. G. Bagnoli, Fabio Manetti, Andrea G. O. |
author_facet | Boero, Elena Cruz, Ana Rita Pansegrau, Werner Giovani, Cinzia Rooijakkers, Suzan H. M. van Kessel, Kok P. M. van Strijp, Jos A. G. Bagnoli, Fabio Manetti, Andrea G. O. |
author_sort | Boero, Elena |
collection | PubMed |
description | Staphylococcal protein A (SpA) is a multifunctional, highly conserved virulence factor of Staphylococcus aureus. By binding the Fc portion of all human IgG subclasses apart from IgG3, SpA interferes with antibody and complement deposition on the bacterial surface, impairing staphylococcal clearance by phagocytosis. Because of its anti-opsonic properties, SpA is not investigated as a surface antigen to mediate bacterial phagocytosis. Herein we investigate human sera for the presence of SpA-opsonizing antibodies. The screening revealed that sera containing IgG3 against SpA were able to correctly opsonize the target and drive Fcγ receptor-mediated interactions and phagocytosis. We demonstrated that IgG3 Fc is significantly more efficient in inducing phagocytosis of SpA-expressing S. aureus as compared to IgG1 Fc in an assay resembling physiological conditions. Furthermore, we show that the capacity of SpA antibodies to induce phagocytosis depends on the specific epitope recognized by the IgGs on SpA molecules. Overall, our results suggest that anti-SpA IgG3 antibodies could favor the anti-staphylococcal response in humans, paving the way towards the identification of a correlate of protection against staphylococcal infections. |
format | Online Article Text |
id | pubmed-8963248 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-89632482022-03-30 Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3 Boero, Elena Cruz, Ana Rita Pansegrau, Werner Giovani, Cinzia Rooijakkers, Suzan H. M. van Kessel, Kok P. M. van Strijp, Jos A. G. Bagnoli, Fabio Manetti, Andrea G. O. Front Immunol Immunology Staphylococcal protein A (SpA) is a multifunctional, highly conserved virulence factor of Staphylococcus aureus. By binding the Fc portion of all human IgG subclasses apart from IgG3, SpA interferes with antibody and complement deposition on the bacterial surface, impairing staphylococcal clearance by phagocytosis. Because of its anti-opsonic properties, SpA is not investigated as a surface antigen to mediate bacterial phagocytosis. Herein we investigate human sera for the presence of SpA-opsonizing antibodies. The screening revealed that sera containing IgG3 against SpA were able to correctly opsonize the target and drive Fcγ receptor-mediated interactions and phagocytosis. We demonstrated that IgG3 Fc is significantly more efficient in inducing phagocytosis of SpA-expressing S. aureus as compared to IgG1 Fc in an assay resembling physiological conditions. Furthermore, we show that the capacity of SpA antibodies to induce phagocytosis depends on the specific epitope recognized by the IgGs on SpA molecules. Overall, our results suggest that anti-SpA IgG3 antibodies could favor the anti-staphylococcal response in humans, paving the way towards the identification of a correlate of protection against staphylococcal infections. Frontiers Media S.A. 2022-03-11 /pmc/articles/PMC8963248/ /pubmed/35359919 http://dx.doi.org/10.3389/fimmu.2022.834711 Text en Copyright © 2022 Boero, Cruz, Pansegrau, Giovani, Rooijakkers, van Kessel, van Strijp, Bagnoli and Manetti https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Boero, Elena Cruz, Ana Rita Pansegrau, Werner Giovani, Cinzia Rooijakkers, Suzan H. M. van Kessel, Kok P. M. van Strijp, Jos A. G. Bagnoli, Fabio Manetti, Andrea G. O. Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3 |
title | Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3 |
title_full | Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3 |
title_fullStr | Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3 |
title_full_unstemmed | Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3 |
title_short | Natural Human Immunity Against Staphylococcal Protein A Relies on Effector Functions Triggered by IgG3 |
title_sort | natural human immunity against staphylococcal protein a relies on effector functions triggered by igg3 |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8963248/ https://www.ncbi.nlm.nih.gov/pubmed/35359919 http://dx.doi.org/10.3389/fimmu.2022.834711 |
work_keys_str_mv | AT boeroelena naturalhumanimmunityagainststaphylococcalproteinareliesoneffectorfunctionstriggeredbyigg3 AT cruzanarita naturalhumanimmunityagainststaphylococcalproteinareliesoneffectorfunctionstriggeredbyigg3 AT pansegrauwerner naturalhumanimmunityagainststaphylococcalproteinareliesoneffectorfunctionstriggeredbyigg3 AT giovanicinzia naturalhumanimmunityagainststaphylococcalproteinareliesoneffectorfunctionstriggeredbyigg3 AT rooijakkerssuzanhm naturalhumanimmunityagainststaphylococcalproteinareliesoneffectorfunctionstriggeredbyigg3 AT vankesselkokpm naturalhumanimmunityagainststaphylococcalproteinareliesoneffectorfunctionstriggeredbyigg3 AT vanstrijpjosag naturalhumanimmunityagainststaphylococcalproteinareliesoneffectorfunctionstriggeredbyigg3 AT bagnolifabio naturalhumanimmunityagainststaphylococcalproteinareliesoneffectorfunctionstriggeredbyigg3 AT manettiandreago naturalhumanimmunityagainststaphylococcalproteinareliesoneffectorfunctionstriggeredbyigg3 |